MIM
ESV

MetLife Investment Management’s Ensco Rowan plc ESV Stock Holding History

MetLife Investment Management’s Portfolio ESV Stock Details ESV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-116,633
Closed -$995K – 2477
2019
Q2 		$995K Buy
116,633
+50,149
+75% +$579K 0.01% 1103
2019
Q1 		$1.05M Buy
66,484
+1
+0% +$17 0.01% 1061
2018
Q4 		$947K Sell
66,483
-270
-0.4% -$6.96K 0.01% 1040
2018
Q3 		$2.25M Buy
+66,753
New +$1.91M 0.02% 807

Other funds holding ESV

HP
Hosking Partners London, United Kingdom $3.01B AUM 83.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
JFGIW
Johnson Financial Group Inc (Wisconsin) Racine, Wisconsin $2.76B AUM 19.4% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

MetLife Investment Management's ESV Position: Q3 2019 in Review

MetLife Investment Management sold out of Ensco Rowan plc (ESV) in Q3 2019, closing a stake of 116,633 shares — an estimated $995K sold.

MetLife Investment Management first reported a position in ESV in Q3 2018 and held it in 4 quarters. The position peaked at $2.25M in Q3 2018. 8 funds tracked by Wall St. Rank hold ESV as of Q3 2019.

  • MetLife Investment Management reported no remaining Ensco Rowan plc position as of Q3 2019 after selling out during the quarter.
  • MetLife Investment Management sold 116,633 Ensco Rowan plc shares in Q3 2019, an estimated $995K.
  • MetLife Investment Management first reported a position in Ensco Rowan plc in Q3 2018 and held it in 4 quarters.
  • MetLife Investment Management's Ensco Rowan plc position peaked at $2.25M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Ensco Rowan plc as of Q3 2019.

Based on MetLife Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.